Dichloromethotrexate - A critical reassessment

P. J. O'Dwyer, B. Leyland-Jones, M. T. Alonso, M. Eisenberger, D. F. Hoth

Research output: Contribution to journalArticlepeer-review

Abstract

We review the biochemical, pharmacologic, and clinical evidence, which indicates that dichloromethotrexate (DCMTX) may in certain circumstances display a therapeutic advantage over the parent compound methotrexate (MTX); studies are suggested to clarify the role of DCMTX in the clinic.

Original languageEnglish (US)
Pages (from-to)1148-1153
Number of pages6
JournalJournal of Clinical Oncology
Volume3
Issue number8
DOIs
StatePublished - Jan 1 1985
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Dichloromethotrexate - A critical reassessment'. Together they form a unique fingerprint.

Cite this